Pollen.com adds new features for allergy season

Share this article:
Pollen.com adds new features for allergy season
Pollen.com adds new features for allergy season
Pollen.com, an allergy site for consumers, is getting revamped with new features for the upcoming allergy season.

New features include a customizable dashboard – MyPollen – that offers allergy information to registered users based on their geographic location, and a Pollen Diary to keep track of symptoms. The dashboard provides local pollen forecasts, top pollen areas with pictures and links, current weather information and historic pollen count information.

For advertisers, the MyPollen dashboard will serve up pharmaceutical and other allergy-related ads that can be geographically targeted to consumers, according to Glenn Connery, associate director of SDI's application development group. Ads are served against geographic-specific content on the four-day forecast function on Pollen.com as well, said Connery.

Pollen.com also has an Allergy Alert iPhone app for accessing four-day forecasts or one-day alerts. Owners of an iPhone can enter a zip code manually, or use an auto-detect function to locate the device geographically. Once a location is determined, alerts and forecasts about pollen, cold and cough, asthma and humidity index levels are delivered direct to the mobile device, according to Connery.

The website, which garners unique visitor traffic in the neighborhood of three million per month during peak allergy season, is maintained in-house. Online marketing firm WebPageFX was enlisted during Pollen.com's redesign to “maximize our exposure to search engines and increase our site's organic traffic,” said Connery.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...